_id
691b165a3c536f8df2318bb2
Ticker
MAAT.PA
Name
Maat Pharma SA
Exchange
PA
Address
70 Avenue Tony Garnier, Lyon, France, 69007
Country
France
Sector
Healthcare
Industry
Biotechnology
Currency
EUR
Website
https://www.maatpharma.com
Description
MaaT Pharma SA, a late-stage clinical company, engages in the development of gut microbiome-driven therapies to modulate the immune system and improve cancer survival. Its products pipeline includes MaaT013, that is in pivotal phase 3 clinical trial for the treatment of acute graft versus host diseases with gastrointestinal involvement; MaaT033, which is in phase 2b clinical trial for the improvement of survival at 12 months for patients with blood cancer receiving allogenic hematopoietic stem cell transplantation; and MaaT03X for the treatment of solid tumors, as well as MaaT034 that optimize immune checkpoint inhibitor treatment. The company was incorporated in 2014 and is headquartered in Lyon, France.
Last Close
4.75
Volume
82447
Current Price
5.08
Change
0.05
Last Updated
2025-12-31T15:57:06.057Z
Image
https://logo.clearbit.com/www.maatpharma.com
Ipo Date
-
Market Cap
89257240
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4.25
Strong Buy
1
Buy
3
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-06-30
Revenue
2427000
Cost Of Revenue
790000
Gross Profit
1637000
Operating Expenses
16386000
Operating Income
-14749000
Interest Expense
422000
Pretax Income
-15085000
Net Income
-15085000
Eps
-0.9981939207905828
Dividends Per Share
-
Shares Outstanding
18751521
Income Tax Expense
-
EBITDA
-14635500
Operating Margin
-607.704985578904
Total Other Income Expense Net
-336000
Cash
15038000
Short Term Investments
31000
Receivables
18233000
Inventories
89000
Total Current Assets
35572000
Property Plant Equipment
7910000
Total Assets
48878000
Payables
10169000
Short Term Debt
2547000
Long Term Debt
7366000
Total Liabilities
40583000
Equity
8295000
Bs_currency_symbol
EUR
Depreciation
113500
Change In Working Capital
-2114000
Cash From Operations
-15373000
Capital Expenditures
202000
Cash From Investing
-223000
Cash From Financing
10481000
Net Change In Cash
-5116000
Cf_currency_symbol
-
PE
-
PB
9.25502754912598
ROE
-181.85654008438817
ROA
-30.862555751053645
FCF
-15575000
Fcf Percent
-6.417387721466832
Piotroski FScore
0
Health Score
8
Deep Value Investing Score
2.5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.3
Garp Investing Score
3
Growth Investing Score
3
Momentum Investing Score
4
Net Net Investing Score
1
Quality Investing Score
1.5
Value Investing Score
2
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
2427000
Quarters > 0 > income Statement > cost Of Revenue
790000
Quarters > 0 > income Statement > gross Profit
1637000
Quarters > 0 > income Statement > operating Expenses
16386000
Quarters > 0 > income Statement > operating Income
-14749000
Quarters > 0 > income Statement > interest Expense
422000
Quarters > 0 > income Statement > pretax Income
-15085000
Quarters > 0 > income Statement > net Income
-15085000
Quarters > 0 > income Statement > eps
-0.9981939207905828
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
15112294
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-14635500
Quarters > 0 > income Statement > operating Margin
-607.704985578904
Quarters > 0 > income Statement > total Other Income Expense Net
-336000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
15038000
Quarters > 0 > balance Sheet > short Term Investments
31000
Quarters > 0 > balance Sheet > receivables
18233000
Quarters > 0 > balance Sheet > inventories
89000
Quarters > 0 > balance Sheet > total Current Assets
35572000
Quarters > 0 > balance Sheet > property Plant Equipment
7910000
Quarters > 0 > balance Sheet > total Assets
48878000
Quarters > 0 > balance Sheet > payables
10169000
Quarters > 0 > balance Sheet > short Term Debt
2547000
Quarters > 0 > balance Sheet > long Term Debt
7366000
Quarters > 0 > balance Sheet > total Liabilities
40583000
Quarters > 0 > balance Sheet > equity
8295000
Quarters > 0 > balance Sheet > currency_symbol
EUR
Quarters > 0 > cash Flow > net Income
-15085000
Quarters > 0 > cash Flow > depreciation
113500
Quarters > 0 > cash Flow > change In Working Capital
-2114000
Quarters > 0 > cash Flow > cash From Operations
-15373000
Quarters > 0 > cash Flow > capital Expenditures
202000
Quarters > 0 > cash Flow > cash From Investing
-223000
Quarters > 0 > cash Flow > cash From Financing
10481000
Quarters > 0 > cash Flow > net Change In Cash
-5116000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.9981939207905828
Quarters > 0 > ratios > PB
9.25502754912598
Quarters > 0 > ratios > ROE
-181.85654008438817
Quarters > 0 > ratios > ROA
-30.862555751053645
Quarters > 0 > ratios > FCF
-15575000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-6.417387721466832
Quarters > 0 > health Score
8
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
1495000
Quarters > 1 > income Statement > cost Of Revenue
1571000
Quarters > 1 > income Statement > gross Profit
-76000
Quarters > 1 > income Statement > operating Expenses
17492000
Quarters > 1 > income Statement > operating Income
-17568000
Quarters > 1 > income Statement > interest Expense
616000
Quarters > 1 > income Statement > pretax Income
-17945000
Quarters > 1 > income Statement > net Income
-16048000
Quarters > 1 > income Statement > eps
-1.1480952764550183
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
13977934
Quarters > 1 > income Statement > income Tax Expense
-1897000
Quarters > 1 > income Statement > EBITDA
-16471000
Quarters > 1 > income Statement > operating Margin
-1175.1170568561872
Quarters > 1 > income Statement > total Other Income Expense Net
-377000
Quarters > 1 > income Statement > currency_symbol
EUR
Quarters > 1 > balance Sheet > cash
20154000
Quarters > 1 > balance Sheet > short Term Investments
66000
Quarters > 1 > balance Sheet > receivables
1514000
Quarters > 1 > balance Sheet > inventories
64000
Quarters > 1 > balance Sheet > total Current Assets
27643000
Quarters > 1 > balance Sheet > property Plant Equipment
8603000
Quarters > 1 > balance Sheet > total Assets
38501000
Quarters > 1 > balance Sheet > payables
8827000
Quarters > 1 > balance Sheet > short Term Debt
3127000
Quarters > 1 > balance Sheet > long Term Debt
7804000
Quarters > 1 > balance Sheet > total Liabilities
28165000
Quarters > 1 > balance Sheet > equity
10336000
Quarters > 1 > balance Sheet > currency_symbol
EUR
Quarters > 1 > cash Flow > net Income
-16048000
Quarters > 1 > cash Flow > depreciation
858000
Quarters > 1 > cash Flow > change In Working Capital
4798000
Quarters > 1 > cash Flow > cash From Operations
-9423000
Quarters > 1 > cash Flow > capital Expenditures
581000
Quarters > 1 > cash Flow > cash From Investing
-597000
Quarters > 1 > cash Flow > cash From Financing
-976000
Quarters > 1 > cash Flow > net Change In Cash
-10996000
Quarters > 1 > cash Flow > currency_symbol
EUR
Quarters > 1 > ratios > PE
-1.1480952764550183
Quarters > 1 > ratios > PB
6.869959821981424
Quarters > 1 > ratios > ROE
-155.26315789473685
Quarters > 1 > ratios > ROA
-41.68203423287707
Quarters > 1 > ratios > FCF
-10004000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-6.691638795986622
Quarters > 1 > health Score
13
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
1721000
Quarters > 2 > income Statement > cost Of Revenue
537000
Quarters > 2 > income Statement > gross Profit
1184000
Quarters > 2 > income Statement > operating Expenses
13940000
Quarters > 2 > income Statement > operating Income
-12756000
Quarters > 2 > income Statement > interest Expense
262000
Quarters > 2 > income Statement > pretax Income
-14476000
Quarters > 2 > income Statement > net Income
-12856000
Quarters > 2 > income Statement > eps
-1.0541721140972398
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
12195352
Quarters > 2 > income Statement > income Tax Expense
-1620000
Quarters > 2 > income Statement > EBITDA
-12639000
Quarters > 2 > income Statement > operating Margin
-741.1969785008716
Quarters > 2 > income Statement > total Other Income Expense Net
-1720000
Quarters > 2 > income Statement > currency_symbol
EUR
Quarters > 2 > balance Sheet > cash
31150000
Quarters > 2 > balance Sheet > short Term Investments
948000
Quarters > 2 > balance Sheet > receivables
7298000
Quarters > 2 > balance Sheet > inventories
179000
Quarters > 2 > balance Sheet > total Current Assets
40646000
Quarters > 2 > balance Sheet > property Plant Equipment
8522000
Quarters > 2 > balance Sheet > total Assets
50923000
Quarters > 2 > balance Sheet > payables
5704000
Quarters > 2 > balance Sheet > short Term Debt
7107000
Quarters > 2 > balance Sheet > long Term Debt
5324000
Quarters > 2 > balance Sheet > total Liabilities
25312000
Quarters > 2 > balance Sheet > equity
25611000
Quarters > 2 > balance Sheet > currency_symbol
EUR
Quarters > 2 > cash Flow > net Income
-12856000
Quarters > 2 > cash Flow > depreciation
834000
Quarters > 2 > cash Flow > change In Working Capital
-776000
Quarters > 2 > cash Flow > cash From Operations
-12702000
Quarters > 2 > cash Flow > capital Expenditures
126000
Quarters > 2 > cash Flow > cash From Investing
-220000
Quarters > 2 > cash Flow > cash From Financing
19792000
Quarters > 2 > cash Flow > net Change In Cash
6870000
Quarters > 2 > cash Flow > currency_symbol
EUR
Quarters > 2 > ratios > PE
-1.0541721140972398
Quarters > 2 > ratios > PB
2.4189757588536174
Quarters > 2 > ratios > ROE
-50.19718089883253
Quarters > 2 > ratios > ROA
-25.24595958604167
Quarters > 2 > ratios > FCF
-12828000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-7.453805926786752
Quarters > 2 > health Score
31
Quarters > 3 > quarter
2024-03-31
Quarters > 3 > income Statement > revenue
860500
Quarters > 3 > income Statement > cost Of Revenue
268500
Quarters > 3 > income Statement > gross Profit
592000
Quarters > 3 > income Statement > operating Expenses
6970000
Quarters > 3 > income Statement > operating Income
-6378000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-6428000
Quarters > 3 > income Statement > net Income
-6428000
Quarters > 3 > income Statement > eps
-0.5270860570486199
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
12195352
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-6319500
Quarters > 3 > income Statement > operating Margin
-741.1969785008716
Quarters > 3 > income Statement > total Other Income Expense Net
-50000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
31150000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
6660000
Quarters > 3 > balance Sheet > inventories
179000
Quarters > 3 > balance Sheet > total Current Assets
40646000
Quarters > 3 > balance Sheet > property Plant Equipment
8522000
Quarters > 3 > balance Sheet > total Assets
50923000
Quarters > 3 > balance Sheet > payables
5704000
Quarters > 3 > balance Sheet > short Term Debt
7107000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
25312000
Quarters > 3 > balance Sheet > equity
25611000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-6428000
Quarters > 3 > cash Flow > depreciation
417000
Quarters > 3 > cash Flow > change In Working Capital
-388000
Quarters > 3 > cash Flow > cash From Operations
-6304000
Quarters > 3 > cash Flow > capital Expenditures
63000
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
9768500
Quarters > 3 > cash Flow > net Change In Cash
3435000
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.5270860570486199
Quarters > 3 > ratios > PB
2.4189757588536174
Quarters > 3 > ratios > ROE
-25.098590449416264
Quarters > 3 > ratios > ROA
-12.622979793020836
Quarters > 3 > ratios > FCF
-6367000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-7.399186519465427
Quarters > 3 > health Score
31
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
3216000
Annuals > 0 > income Statement > cost Of Revenue
1250000
Annuals > 0 > income Statement > gross Profit
1966000
Annuals > 0 > income Statement > operating Expenses
30394000
Annuals > 0 > income Statement > operating Income
-28428000
Annuals > 0 > income Statement > interest Expense
868000
Annuals > 0 > income Statement > pretax Income
-32421000
Annuals > 0 > income Statement > net Income
-28904000
Annuals > 0 > income Statement > eps
-2.2123975089861427
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
13064560
Annuals > 0 > income Statement > income Tax Expense
-3517000
Annuals > 0 > income Statement > EBITDA
-26344000
Annuals > 0 > income Statement > operating Margin
-883.955223880597
Annuals > 0 > income Statement > total Other Income Expense Net
-3993000
Annuals > 0 > income Statement > currency_symbol
EUR
Annuals > 0 > balance Sheet > cash
20154000
Annuals > 0 > balance Sheet > short Term Investments
66000
Annuals > 0 > balance Sheet > receivables
1514000
Annuals > 0 > balance Sheet > inventories
64000
Annuals > 0 > balance Sheet > total Current Assets
27643000
Annuals > 0 > balance Sheet > property Plant Equipment
8603000
Annuals > 0 > balance Sheet > total Assets
38501000
Annuals > 0 > balance Sheet > payables
8827000
Annuals > 0 > balance Sheet > short Term Debt
3127000
Annuals > 0 > balance Sheet > long Term Debt
7804000
Annuals > 0 > balance Sheet > total Liabilities
28165000
Annuals > 0 > balance Sheet > equity
10336000
Annuals > 0 > balance Sheet > currency_symbol
EUR
Annuals > 0 > cash Flow > net Income
-28904000
Annuals > 0 > cash Flow > depreciation
1692000
Annuals > 0 > cash Flow > change In Working Capital
3377000
Annuals > 0 > cash Flow > cash From Operations
-22041000
Annuals > 0 > cash Flow > capital Expenditures
753000
Annuals > 0 > cash Flow > cash From Investing
-416000
Annuals > 0 > cash Flow > cash From Financing
18331000
Annuals > 0 > cash Flow > net Change In Cash
-4126000
Annuals > 0 > cash Flow > currency_symbol
EUR
Annuals > 0 > ratios > PE
-2.2123975089861427
Annuals > 0 > ratios > PB
6.079772987616098
Annuals > 0 > ratios > ROE
-279.64396284829724
Annuals > 0 > ratios > ROA
-75.0733747175398
Annuals > 0 > ratios > FCF
-22794000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-7.087686567164179
Annuals > 0 > health Score
12
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
2228000
Annuals > 1 > income Statement > cost Of Revenue
1444000
Annuals > 1 > income Statement > gross Profit
784000
Annuals > 1 > income Statement > operating Expenses
25394000
Annuals > 1 > income Statement > operating Income
-19943000
Annuals > 1 > income Statement > interest Expense
413000
Annuals > 1 > income Statement > pretax Income
-19717000
Annuals > 1 > income Statement > net Income
-19717000
Annuals > 1 > income Statement > eps
-1.734887202855362
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
11365004
Annuals > 1 > income Statement > income Tax Expense
-3633000
Annuals > 1 > income Statement > EBITDA
-22066000
Annuals > 1 > income Statement > operating Margin
-895.1077199281867
Annuals > 1 > income Statement > total Other Income Expense Net
226000
Annuals > 1 > income Statement > currency_symbol
EUR
Annuals > 1 > balance Sheet > cash
24280000
Annuals > 1 > balance Sheet > short Term Investments
34000
Annuals > 1 > balance Sheet > receivables
5164000
Annuals > 1 > balance Sheet > inventories
190000
Annuals > 1 > balance Sheet > total Current Assets
31994000
Annuals > 1 > balance Sheet > property Plant Equipment
9172000
Annuals > 1 > balance Sheet > total Assets
42931000
Annuals > 1 > balance Sheet > payables
6349000
Annuals > 1 > balance Sheet > short Term Debt
3455000
Annuals > 1 > balance Sheet > long Term Debt
5425000
Annuals > 1 > balance Sheet > total Liabilities
22465000
Annuals > 1 > balance Sheet > equity
20466000
Annuals > 1 > balance Sheet > currency_symbol
EUR
Annuals > 1 > cash Flow > net Income
-19717000
Annuals > 1 > cash Flow > depreciation
871000
Annuals > 1 > cash Flow > change In Working Capital
-384000
Annuals > 1 > cash Flow > cash From Operations
-18670000
Annuals > 1 > cash Flow > capital Expenditures
1093000
Annuals > 1 > cash Flow > cash From Investing
-440000
Annuals > 1 > cash Flow > cash From Financing
8141000
Annuals > 1 > cash Flow > net Change In Cash
-10968000
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
-1.734887202855362
Annuals > 1 > ratios > PB
2.671048042607251
Annuals > 1 > ratios > ROE
-96.34027167008698
Annuals > 1 > ratios > ROA
-45.92718548368312
Annuals > 1 > ratios > FCF
-19763000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-8.87028725314183
Annuals > 1 > health Score
24
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
1430000
Annuals > 2 > income Statement > cost Of Revenue
339000
Annuals > 2 > income Statement > gross Profit
1091000
Annuals > 2 > income Statement > operating Expenses
14647000
Annuals > 2 > income Statement > operating Income
-13556000
Annuals > 2 > income Statement > interest Expense
201000
Annuals > 2 > income Statement > pretax Income
-13713000
Annuals > 2 > income Statement > net Income
-13713000
Annuals > 2 > income Statement > eps
-1.3863018656390125
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
9891785
Annuals > 2 > income Statement > income Tax Expense
157000
Annuals > 2 > income Statement > EBITDA
-13099000
Annuals > 2 > income Statement > operating Margin
-947.972027972028
Annuals > 2 > income Statement > total Other Income Expense Net
-156000
Annuals > 2 > income Statement > currency_symbol
EUR
Annuals > 2 > balance Sheet > cash
35248000
Annuals > 2 > balance Sheet > short Term Investments
63000
Annuals > 2 > balance Sheet > receivables
1047000
Annuals > 2 > balance Sheet > inventories
47000
Annuals > 2 > balance Sheet > total Current Assets
42124000
Annuals > 2 > balance Sheet > property Plant Equipment
966000
Annuals > 2 > balance Sheet > total Assets
44726000
Annuals > 2 > balance Sheet > payables
4507000
Annuals > 2 > balance Sheet > short Term Debt
2969000
Annuals > 2 > balance Sheet > long Term Debt
7926000
Annuals > 2 > balance Sheet > total Liabilities
17915000
Annuals > 2 > balance Sheet > equity
26811000
Annuals > 2 > balance Sheet > currency_symbol
EUR
Annuals > 2 > cash Flow > net Income
-13713000
Annuals > 2 > cash Flow > depreciation
429000
Annuals > 2 > cash Flow > change In Working Capital
-50000
Annuals > 2 > cash Flow > cash From Operations
-12605000
Annuals > 2 > cash Flow > capital Expenditures
662000
Annuals > 2 > cash Flow > cash From Investing
-815000
Annuals > 2 > cash Flow > cash From Financing
5364000
Annuals > 2 > cash Flow > net Change In Cash
-8057000
Annuals > 2 > cash Flow > currency_symbol
EUR
Annuals > 2 > ratios > PE
-1.3863018656390125
Annuals > 2 > ratios > PB
1.7746255585394053
Annuals > 2 > ratios > ROE
-51.1469173100593
Annuals > 2 > ratios > ROA
-30.660018781022224
Annuals > 2 > ratios > FCF
-13267000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-9.277622377622377
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
972000
Annuals > 3 > income Statement > cost Of Revenue
166000
Annuals > 3 > income Statement > gross Profit
806000
Annuals > 3 > income Statement > operating Expenses
9699000
Annuals > 3 > income Statement > operating Income
-8893000
Annuals > 3 > income Statement > interest Expense
121000
Annuals > 3 > income Statement > pretax Income
-9019000
Annuals > 3 > income Statement > net Income
-9019000
Annuals > 3 > income Statement > eps
-3.716828674350338
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
2426531
Annuals > 3 > income Statement > income Tax Expense
121000
Annuals > 3 > income Statement > EBITDA
-8570000
Annuals > 3 > income Statement > operating Margin
-914.9176954732511
Annuals > 3 > income Statement > total Other Income Expense Net
-126000
Annuals > 3 > income Statement > currency_symbol
EUR
Annuals > 3 > balance Sheet > cash
43304000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
3507000
Annuals > 3 > balance Sheet > inventories
33000
Annuals > 3 > balance Sheet > total Current Assets
47269000
Annuals > 3 > balance Sheet > property Plant Equipment
1107000
Annuals > 3 > balance Sheet > total Assets
49420000
Annuals > 3 > balance Sheet > payables
34000
Annuals > 3 > balance Sheet > short Term Debt
1254000
Annuals > 3 > balance Sheet > long Term Debt
3961000
Annuals > 3 > balance Sheet > total Liabilities
9564000
Annuals > 3 > balance Sheet > equity
39856000
Annuals > 3 > balance Sheet > currency_symbol
EUR
Annuals > 3 > cash Flow > net Income
-9019000
Annuals > 3 > cash Flow > depreciation
328000
Annuals > 3 > cash Flow > change In Working Capital
-210000
Annuals > 3 > cash Flow > cash From Operations
-7929000
Annuals > 3 > cash Flow > capital Expenditures
238000
Annuals > 3 > cash Flow > cash From Investing
-238000
Annuals > 3 > cash Flow > cash From Financing
31558000
Annuals > 3 > cash Flow > net Change In Cash
23392000
Annuals > 3 > cash Flow > currency_symbol
EUR
Annuals > 3 > ratios > PE
-3.716828674350338
Annuals > 3 > ratios > PB
0.29284459328582896
Annuals > 3 > ratios > ROE
-22.628964271376958
Annuals > 3 > ratios > ROA
-18.249696479158235
Annuals > 3 > ratios > FCF
-8167000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-8.402263374485596
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.9981939207905828
Valuation > metrics > PB
9.25502754912598
Valuation > final Score
20
Valuation > verdict
208.5% Overvalued
Profitability > metrics > ROE
-181.85654008438817
Profitability > metrics > ROA
-42.40694928595525
Profitability > metrics > Net Margin
-6.215492377420684
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
4.8924653405666065
Risk > metrics > Interest Coverage
-34.95023696682465
Risk > final Score
-134
Risk > verdict
High
Liquidity > metrics > Current Ratio
2.7974205725070775
Liquidity > metrics > Quick Ratio
2.790421516200063
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
80
Prev Valuations > 2
80
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-96
Prev Risks > 1
-147
Prev Risks > 2
-187
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:10:10.878Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-30
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-04
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-09-17
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-1
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-1
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-04-14
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-1.15
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
-1.15
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-03-27
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-1.15
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-1.15
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-05
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
0
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-09-19
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
0
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-04-02
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
EUR
Earnings History > 7 > eps Actual
0
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-28
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
-
Earnings History > 8 > eps Actual
0
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-09
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
EUR
Earnings History > 9 > eps Actual
0
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-07-27
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
EUR
Earnings History > 10 > eps Actual
0
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-09
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
EUR
Earnings History > 11 > eps Actual
0
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-03-30
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
EUR
Earnings History > 12 > eps Actual
-0.64
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.64
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-08
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
EUR
Earnings History > 13 > eps Actual
0
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-07-28
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
EUR
Earnings History > 14 > eps Actual
-0.75
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.75
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-04-14
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
EUR
Earnings History > 15 > eps Actual
-0.48
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-0.48
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-10-20
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
EUR
Earnings History > 16 > eps Actual
-0.23
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.23
Earnings History > 16 > surprise Percent
-
MaaT Pharma SA, a late-stage clinical company, engages in the development of gut microbiome-driven therapies to modulate the immune system and improve cancer survival. Its products pipeline includes MaaT013, that is in pivotal phase 3 clinical trial for the treatment of acute graft versus host diseases with gastrointestinal involvement; MaaT033, which is in phase 2b clinical trial for the improvement of survival at 12 months for patients with blood cancer receiving allogenic hematopoietic stem cell transplantation; and MaaT03X for the treatment of solid tumors, as well as MaaT034 that optimize immune checkpoint inhibitor treatment. The company was incorporated in 2014 and is headquartered in Lyon, France.
Stock Price
€0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AAnalysts Expect Breakeven For MaaT Pharma SA (EPA:MAAT) Before Long simplywall.st
Read more →Showing 2 of 6
(Last Updated 2025-06-30)
Rating:
BUY
$
Analyst Picks
Strong Buy
1
Buy
3
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Maat Pharma SA
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
0
Date
2025-09-30
EPS Actual
0
EPS Estimate
0
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
€ 0
Cost Of Revenue
€ 0
Gross Profit
€ 0
Operating Expenses
€ 0
Operating Income
€ 0
Interest Expense
€ 0
Pretax Income
€ 0
Net Income
€ 0
Income Tax Expense
€ 0
EBITDA
€ 0
Total Other Income Expense Net
€ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
€ 0
Short Term Investments
€ 0
Receivables
€ 0
Inventories
€ 0
Total Current Assets
€ 0
Property Plant Equipment
€ 0
Total Assets
€ 0
Payables
€ 0
Short Term Debt
€ 0
Long Term Debt
€ 0
Total Liabilities
€ 0
Equity
€ 0
(Last Updated 2025-06-30)
Net Income
€ 0
Depreciation
€ 0
Change In Working Capital
€ 0
Cash From Operations
€ 0
Capital Expenditures
€ 0
Cash From Investing
€ 0
Cash From Financing
€ 0
Net Change In Cash
€ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.